R. E. Blount, J. A. Morris, and R. E. Savage, Recovery of cytopathogenic agent from chimpanzees with goryza, Proceedings of the Society for Experimental Biology and Medicine, vol.92, issue.3, pp.544-549, 1956.

R. Chanock and L. Finberg, Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA), American Journal of Epidemiology, vol.66, issue.3, pp.291-300, 1957.

R. Chanock, B. Roizman, and R. Myers, Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). Isolation, properties and characterization, American Journal of Epidemiology, vol.66, issue.3, pp.281-290, 1957.

C. L. Afonso, G. K. Amarasinghe, and K. Bányai, Taxonomy of the order Mononegavirales: update 2016, vol.161, pp.2351-2360, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01911212

M. Connors, P. L. Collins, C. Y. Firestone, and B. R. Murphy, Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived, Journal of Virology, vol.65, issue.3, pp.1634-1637, 1991.

S. Jain, W. H. Self, R. G. Wunderink, and C. Team, Community-acquired pneumonia requiring hospitalization, New England Journal of Medicine, vol.373, issue.24, p.2382, 2015.

A. Jha, H. Jarvis, C. Fraser, and P. J. Openshaw, Respiratory syncytial virus, SARS, MERS and Other Viral Lung, vol.72, pp.84-109, 2016.

T. Shi, D. A. Mcallister, and K. L. O'brien, Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study, The Lancet, vol.390, issue.10098, pp.946-958, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01976733

N. Sigurs, F. Aljassim, and B. Kjellman, Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life, Thorax, vol.65, issue.12, pp.1045-1052, 2010.

H. W. Kim, J. G. Canchola, and C. D. Brandt, Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine, American Journal of Epidemiology, vol.89, issue.4, pp.422-434, 1969.

M. Connors, N. A. Giese, A. B. Kulkarni, C. Y. Firestone, H. C. Morse et al., Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10, Journal of Virology, vol.68, issue.8, pp.5321-5325, 1994.

M. E. Waris, C. Tsou, D. D. Erdman, S. R. Zaki, and L. J. Anderson, Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern, Journal of Immunology Research, vol.70, issue.5, pp.2852-2860, 1996.

R. Janssen, L. Bont, and C. L. Siezen, Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes, The Journal of Infectious Diseases, vol.196, issue.6, pp.826-834, 2007.

L. Lambert, A. M. Sagfors, P. J. Openshaw, and F. J. Culley, Immunity to RSV in early-life, Frontiers in Immunology, vol.5, p.466, 2014.

S. A. Cormier, D. You, and S. Honnegowda, The use of a neonatal mouse model to study respiratory syncytial virus infections, Expert Review of Anti-Infective Therapy, vol.8, issue.12, pp.1371-1380, 2010.

R. Ochola, C. Sande, and G. Fegan, The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya, PLoS One, vol.4, issue.12, p.8088, 2009.

C. J. Sande, P. A. Cane, and D. J. Nokes, The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants, Vaccine, vol.32, issue.37, pp.4726-4729, 2014.

M. O. Blanken, M. M. Rovers, and J. M. Molenaar, Respiratory syncytial virus and recurrent wheeze in healthy preterm infants, New England Journal of Medicine, vol.368, issue.19, pp.1791-1799, 2013.

F. J. Culley, J. Pollott, and P. J. Openshaw, Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood, The Journal of Experimental Medicine, vol.196, issue.10, pp.1381-1386, 2002.

A. Dakhama, J. W. Park, and C. Taube, The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production, Journal of Immunology, vol.175, issue.3, pp.1876-1883, 2005.

J. C. Schittny, Development of the lung, Cell and Tissue Research, vol.367, issue.3, pp.427-444, 2017.

S. I. Mund, M. Stampanoni, and J. C. Schittny, Developmental alveolarization of the mouse lung, Developmental Dynamics, vol.237, issue.8, pp.2108-2116, 2008.

E. S. Gollwitzer and B. J. Marsland, Impact of early-life exposures on immune maturation and susceptibility to disease, Trends in Immunology, vol.36, issue.11, pp.684-696, 2015.

C. M. Lloyd and B. J. Marsland, Lung homeostasis: influence of age, microbes, and the immune system, Immunity, vol.46, issue.4, pp.549-561, 2017.

M. Guilliams, I. De-kleer, and S. Henri, Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF, The Journal of Experimental Medicine, vol.210, issue.10, pp.1977-1992, 2013.

C. Schneider, S. P. Nobs, M. Kurrer, H. Rehrauer, C. Thiele et al., Induction of the nuclear receptor PPAR-? by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages, Nature Immunology, vol.15, issue.11, pp.1026-1037, 2014.

I. M. De-kleer, M. Kool, and M. J. De-bruijn, Perinatal activation of the interleukin-33 pathway promotes type 2 immunity in the developing lung, Immunity, vol.45, issue.6, pp.1285-1298, 2016.

B. L. Manroe, A. G. Weinberg, C. R. Rosenfeld, and R. Browne, The neonatal blood count in health and disease. I. Reference values for neutrophilic cells, The Journal of Pediatrics, vol.95, issue.1, pp.89-98, 1979.

H. S. Deshmukh, Y. Liu, and O. R. Menkiti, The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice, Nature Medicine, vol.20, issue.5, pp.524-530, 2014.

S. Saluzzo, A. D. Gorki, and B. M. Rana, Firstbreath-induced type 2 pathways shape the lung immune environment, Cell Reports, vol.18, issue.8, pp.1893-1905, 2017.

A. M. Miller, Role of IL-33 in inflammation and disease, Journal of Inflammation, vol.8, issue.1, p.22, 2011.

J. Lu, J. Kang, C. Zhang, and X. Zhang, The role of IL-33/ ST2L signals in the immune cells, Immunology Letters, vol.164, issue.1, pp.11-17, 2015.

H. Spits, D. Artis, and M. Colonna, Innate lymphoid cellsa proposal for uniform nomenclature, Nature Reviews Immunology, vol.13, issue.2, pp.145-149, 2013.

G. Gasteiger, X. Fan, S. Dikiy, S. Y. Lee, and A. Y. Rudensky, Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs, Science, vol.350, issue.6263, pp.981-985, 2015.

C. H. Kim, S. Hashimoto-hill, and M. Kim, Migration and tissue tropism of innate lymphoid cells, Trends in Immunology, vol.37, issue.1, pp.68-79, 2016.

C. Gregoire, L. Chasson, and C. Luci, The trafficking of natural killer cells, Immunological Reviews, vol.220, pp.169-182, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00297259

M. Greter, J. Helft, and A. Chow, GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells, Immunity, vol.36, issue.6, pp.1031-1046, 2012.

X. Roux, A. Remot, and A. Petit-camurdan, Neonatal lung immune responses show a shift of cytokines and transcription factors toward Th2 and a deficit in conventional and plasmacytoid dendritic cells, European Journal of Immunology, vol.41, issue.10, pp.2852-2861, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02644846

J. Han, A. Dakhama, and Y. Jia, Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand, The Journal of Allergy and Clinical Immunology, vol.130, issue.5, pp.1175-1186, 2012.

C. M. Sun, E. Deriaud, C. Leclerc, and R. Lo-man, Upon TLR9 signaling, CD5 + B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs, Immunity, vol.22, issue.4, pp.467-477, 2005.

D. Zhivaki, S. Lemoine, and A. Lim, Respiratory syncytial virus infects regulatory B cells in human neonates via chemokine receptor CX3CR1 and promotes lung disease severity, Immunity, vol.46, issue.2, pp.301-314, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01604975

E. S. Gollwitzer, S. Saglani, and A. Trompette, Lung microbiota promotes tolerance to allergens in neonates via PD-L1, Nature Medicine, vol.20, issue.6, pp.642-647, 2014.

A. Remot, D. Descamps, and M. L. Noordine, Bacteria isolated from lung modulate asthma susceptibility in mice, The ISME Journal, vol.11, issue.5, pp.1061-1074, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01595509

Y. Yun, G. Srinivas, and S. Kuenzel, Environmentally determined differences in the murine lung microbiota and their relation to alveolar architecture, PLoS One, vol.9, issue.12, p.113466, 2014.

T. Olszak, D. An, and S. Zeissig, Microbial exposure during early life has persistent effects on natural killer T cell function, Science, vol.336, issue.6080, pp.489-493, 2012.

T. Gensollen, S. S. Iyer, D. L. Kasper, and R. S. Blumberg, How colonization by microbiota in early life shapes the immune system, Science, vol.352, issue.6285, pp.539-544, 2016.

C. Johansson, Respiratory syncytial virus infection: an innate perspective, F1000Research, vol.5, p.2898, 2016.

T. H. Kim and H. K. Lee, Innate immune recognition of respiratory syncytial virus infection, BMB Reports, vol.47, issue.4, pp.184-191, 2014.

N. Marr, S. E. Turvey, and N. Grandvaux, Pathogen recognition receptor crosstalk in respiratory syncytial virus sensing: a host and cell type perspective, Trends in Microbiology, vol.21, issue.11, pp.568-574, 2013.

R. Zeng, Y. Cui, Y. Hai, and Y. Liu, Pattern recognition receptors for respiratory syncytial virus infection and design of vaccines, Virus Research, vol.167, issue.2, pp.138-145, 2012.

E. A. Kurt-jones, L. Popova, and L. Kwinn, Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus, Nature Immunology, vol.1, issue.5, pp.398-401, 2000.

L. M. Haynes, D. D. Moore, E. A. Kurt-jones, R. W. Finberg, L. J. Anderson et al., Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus, Journal of Virology, vol.75, issue.22, pp.10730-10737, 2001.

S. Ehl, R. Bischoff, and T. Ostler, The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus, European Journal of Immunology, vol.34, issue.4, pp.1146-1153, 2004.

L. Armstrong, A. R. Medford, and K. M. Uppington, Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells, American Journal of Respiratory Cell and Molecular Biology, vol.31, issue.2, pp.241-245, 2004.

K. Suzuki, T. Suda, T. Naito, K. Ide, K. Chida et al., Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA, American Journal of Respiratory and Critical Care Medicine, vol.171, issue.7, pp.707-713, 2005.

M. Vareille, E. Kieninger, M. R. Edwards, and N. Regamey, The airway epithelium: soldier in the fight against respiratory viruses, Clinical Microbiology Reviews, vol.24, issue.1, pp.210-229, 2011.

K. A. Shirey, L. M. Pletneva, and A. C. Puche, Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R?-, TLR4-, and IFN-?-dependent, Mucosal Immunology, vol.3, issue.3, pp.291-300, 2010.

M. R. Murawski, G. N. Bowen, and A. M. Cerny, Respiratory syncytial virus activates innate immunity through Toll-like receptor 2, Journal of Virology, vol.83, issue.3, pp.1492-1500, 2009.

G. F. Sonnenberg and D. Artis, Innate lymphoid cells in the initiation, regulation and resolution of inflammation, Nature Medicine, vol.21, issue.7, pp.698-708, 2015.

T. Ishii, K. Hosoki, Y. Niikura, T. Nagase, and N. Yamashita, The activation of pulmonary type2 innate lymphoid cells through toll-like receptors, American Journal of Respiratory and Critical Care Medicine, vol.195, p.284, 2017.

B. D. Rudd, E. Burstein, C. S. Duckett, X. Li, and N. W. Lukacs, Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression, Journal of Virology, vol.79, issue.6, pp.3350-3357, 2005.

L. Guillot, R. L. Goffic, and S. Bloch, Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus, The Journal of Biological Chemistry, vol.280, issue.7, pp.5571-5580, 2005.

F. Qi, D. Wang, and J. Liu, Respiratory macrophages and dendritic cells mediate respiratory syncytial virus-induced IL-33 production in TLR3-or TLR7-dependent manner, International Immunopharmacology, vol.29, issue.2, pp.408-415, 2015.

T. Demoor, B. C. Petersen, and S. Morris, IPS-1 signaling has a nonredundant role in mediating antiviral responses and the clearance of respiratory syncytial virus, Journal of Immunology, vol.189, issue.12, pp.5942-5953, 2012.

N. W. Lukacs, J. J. Smit, S. Mukherjee, S. B. Morris, G. Nunez et al., Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation, Journal of Immunology, vol.185, issue.4, pp.2231-2239, 2010.

S. Phipps, C. E. Lam, and S. Mahalingam, Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus, Blood, vol.110, issue.5, pp.1578-1586, 2007.

J. Schlender, V. Hornung, and S. Finke, Inhibition of tolllike receptor 7-and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus, Journal of Virology, vol.79, issue.9, pp.5507-5515, 2005.

Y. M. Loo, J. Fornek, and N. Crochet, Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity, Journal of Virology, vol.82, issue.1, pp.335-345, 2008.

N. Marr, T. I. Wang, and S. H. Kam, Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children, Journal of Immunology, vol.192, issue.3, pp.948-957, 2014.

M. Goritzka, S. Makris, and F. Kausar, Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes, The Journal of Experimental Medicine, vol.212, issue.5, pp.699-714, 2015.

A. Sabbah, T. H. Chang, and R. Harnack, Activation of innate immune antiviral responses by Nod2, Nature Immunology, vol.10, issue.10, pp.1073-1080, 2009.

V. G. Bhoj, Q. Sun, and E. J. Bhoj, MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus, Proceedings of the National Academy of Sciences, vol.105, issue.37, pp.14046-14051, 2008.

S. Makris, M. Bajorek, F. J. Culley, M. Goritzka, and C. Johansson, Alveolar macrophages can control respiratory syncytial virus infection in the absence of type I interferons, Journal of Innate Immunity, vol.8, issue.5, pp.452-463, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01602871

A. A. Awomoyi, P. Rallabhandi, and T. I. Pollin, Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children, Journal of Immunology, vol.179, issue.5, pp.3171-3177, 2007.

G. Tal, A. Mandelberg, and I. , Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease, The Journal of Infectious Diseases, vol.189, issue.11, pp.2057-2063, 2004.

M. K. Tulic, R. J. Hurrelbrink, and C. M. Prêle, TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide, Journal of Immunology, vol.179, issue.1, pp.132-140, 2007.

M. Ramet, M. Korppi, and M. Hallman, Pattern recognition receptors and genetic risk for rsv infection: value for clinical decision-making?, Pediatric Pulmonology, vol.46, issue.2, pp.101-110, 2011.

N. Marr, A. F. Hirschfeld, A. Lam, S. Wang, P. M. Lavoie et al., Assessment of genetic associations between common single nucleotide polymorphisms in RIG-I-like receptor and IL-4 signaling genes and severe respiratory syncytial virus infection in children: a candidate gene casecontrol study, PLoS One, vol.9, issue.6, p.100269, 2014.

M. T. Caballero, M. E. Serra, and P. L. Acosta, TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization, The Journal of Clinical Investigation, vol.125, issue.2, pp.571-582, 2015.

T. R. Kollmann, O. Levy, R. R. Montgomery, and S. Goriely, Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly, Immunity, vol.37, issue.5, pp.771-783, 2012.

K. Gabehart, K. A. Correll, J. E. Loader, C. W. White, and A. Dakhama, The lung response to ozone is determined by age and is partially dependent on toll-like receptor 4, Respiratory Research, vol.16, p.117, 2015.

K. Harju, M. Ojaniemi, and S. Rounioja, Expression of tolllike receptor 4 and endotoxin responsiveness in mice during perinatal period, Pediatric Research, vol.57, issue.5, pp.644-648, 2005.

J. S. Tregoning, Y. Yamaguchi, J. Harker, B. Wang, and P. J. Openshaw, The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice, Journal of Virology, vol.82, issue.8, pp.4115-4124, 2008.

A. F. Christiaansen, C. J. Knudson, K. A. Weiss, and S. M. Varga, The CD4 T cell response to respiratory syncytial virus infection, Immunologic Research, vol.59, issue.1-3, pp.109-117, 2014.

T. J. Ruckwardt, A. M. Malloy, K. M. Morabito, and B. S. Graham, Quantitative and qualitative deficits in neonatal lung-migratory dendritic cells impact the generation of the CD8+ T cell response, PLoS Pathogens, vol.10, issue.2, p.1003934, 2014.

S. A. Cormier, B. Shrestha, and J. Saravia, Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection, Journal of Virology, vol.88, issue.16, pp.9350-9360, 2014.

A. Remot, D. Descamps, and L. Jouneau, Flt3 ligand improves the innate response to respiratory syncytial virus and limits lung disease upon RSV reexposure in neonate mice, European Journal of Immunology, vol.46, issue.4, pp.874-884, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01533877

M. Goritzka, L. R. Durant, C. Pereira, S. Salek-ardakani, P. J. Openshaw et al., Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection, Journal of Virology, vol.88, issue.11, pp.6128-6136, 2014.

T. R. Johnson, S. E. Mertz, and N. Gitiban, Role for innate IFNs in determining respiratory syncytial virus immunopathology, Journal of Immunology, vol.174, issue.11, pp.7234-7241, 2005.

K. M. Eichinger, L. Egaña, and J. G. Orend, Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice, Respiratory Research, vol.16, p.122, 2015.

P. K. Pribul, J. Harker, and B. Wang, Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development, Journal of Virology, vol.82, issue.9, pp.4441-4448, 2008.

D. Kolli, M. R. Gupta, and E. Sbrana, Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection, American Journal of Respiratory Cell and Molecular Biology, vol.51, issue.4, pp.502-515, 2014.

T. Hussell and T. J. Bell, Alveolar macrophages: plasticity in a tissue-specific context, Nature Reviews Immunology, vol.14, issue.2, pp.81-93, 2014.

D. M. Mosser and J. P. Edwards, Exploring the full spectrum of macrophage activation, Nature Reviews Immunology, vol.8, issue.12, pp.958-969, 2008.

K. M. Empey, J. G. Orend, and R. S. Peebles, Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection, PLoS One, vol.7, issue.7, p.40499, 2012.

J. Saravia, D. You, and B. Shrestha, Respiratory syncytial virus disease is mediated by age-variable IL-33, PLoS Pathogens, vol.11, issue.10, p.1005217, 2015.

M. L. Garcia-garcia, C. Calvo, and A. Moreira, Thymic stromal lymphopoietin, IL-33, and periostin in hospitalized infants with viral bronchiolitis, Medicine, vol.96, issue.18, p.6787, 2017.

M. T. Stier, M. H. Bloodworth, and S. Toki, Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin, The Journal of Allergy and Clinical Immunology, vol.138, issue.3, pp.814-824, 2016.

S. Sattler, G. S. Ling, and D. Xu, IL-10-producing regulatory B cells induced by IL-33 (Breg IL-33 ) effectively attenuate mucosal inflammatory responses in the gut, Journal of Autoimmunity, vol.50, pp.107-122, 2014.

Y. Yamaguchi, J. A. Harker, B. Wang, P. J. Openshaw, J. S. Tregoning et al., Preexposure to CpG protects against the delayed effects of neonatal respiratory syncytial virus infection, Journal of Virology, vol.86, issue.19, pp.10456-10461, 2012.

M. S. Boukhvalova, T. B. Sotomayor, R. C. Point, L. M. Pletneva, G. A. Prince et al., Activation of interferon response through toll-like receptor 3 impacts viral pathogenesis and pulmonary toll-like receptor expression during respiratory syncytial virus and influenza infections in the cotton rat Sigmodon hispidus model, Journal of Interferon & Cytokine Research, vol.30, issue.4, pp.229-242, 2010.

S. Challa, A. Sheri, and S. Padmanabhan, Prophylactic and therapeutic anti-RSV activity of SB 9200 -a novel agent that activates RIG-I and NOD2, Spring Bank Pharmaceuticals Presents Data on Immunomodulatory Agent SB 9200 at the 29th International Conference on Antiviral Research, 2016.

K. K. Tekkanat, H. F. Maassab, and D. S. Cho, IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent, Journal of Immunology, vol.166, issue.5, pp.3542-3548, 2001.

G. M. Gauvreau, P. M. O'byrne, and L. P. Boulet, Effects of an anti-TSLP antibody on allergen-induced asthmatic responses, New England Journal of Medicine, vol.370, issue.22, pp.2102-2110, 2014.

E. H. De-boever, C. Ashman, and A. P. Cahn, Efficacy and safety of an anti-IL-13 mAb in patients with severe asthma: a randomized trial, Journal of Allergy and Clinical Immunology, vol.133, issue.4, pp.989-996, 2014.

B. Shrestha, D. You, and J. Saravia, IL-4R? on dendritic cells in neonates and Th2 immunopathology in respiratory syncytial virus infection, Journal of Leukocyte Biology, vol.102, issue.1, pp.153-161, 2017.

M. J. Ripple, D. You, and S. Honnegowda, Immunomodulation with IL-4R? antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease, Journal of Immunology, vol.185, issue.8, pp.4804-4811, 2010.

B. T. Srinivasa, K. H. Restori, and J. Shan, STAT6 inhibitory peptide given during RSV infection of neonatal mice reduces exacerbated airway responses upon adult reinfection, Journal of Leukocyte Biology, vol.101, issue.2, pp.519-529, 2017.

Y. M. Lee, N. Miyahara, and K. Takeda, IFN-? production during initial infection determines the outcome of reinfection with respiratory syncytial virus, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.2, pp.208-218, 2008.

K. M. Eichinger, E. Resetar, J. Orend, K. Anderson, and K. M. Empey, Age predicts cytokine kinetics and innate immune cell activation following intranasal delivery of IFN? and GM-CSF in a mouse model of RSV infection, Cytokine, vol.97, pp.25-37, 2017.

J. P. Lynch, M. A. Sikder, and B. F. Curren, The influence of the microbiome on early-life severe viral lower respiratory infections and asthma-food for thought?, Frontiers in Immunology, vol.8, p.156, 2017.

J. Villena, S. Salva, and M. Núñez, Probiotics for everyone! The novel immunobiotic Lactobacillus rhamnosus CRL1505 and the beginning of social probiotic programs in Argentina, International Journal of Biotechnology for Wellness Industries, vol.1, issue.3, pp.189-198, 2012.

J. Villena, E. Chiba, and Y. Tomosada, Orally administered Lactobacillus rhamnosus modulates the respiratory immune response triggered by the viral pathogen-associated molecular pattern poly(I:C), BMC Immunology, vol.13, p.53, 2012.

E. Chiba, Y. Tomosada, and M. G. Vizoso-pinto, Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice against respiratory syncytial virus infection, International Immunopharmacology, vol.17, issue.2, pp.373-382, 2013.

Y. Tomosada, E. Chiba, and H. Zelaya, Nasally administered Lactobacillus rhamnosus strains differentially modulate respiratory antiviral immune responses and induce protection against respiratory syncytial virus infection, BMC Immunology, vol.14, p.40, 2013.

W. A. De-steenhuijsen-piters, S. Heinonen, and R. Hasrat, Nasopharyngeal microbiota, host transcriptome, and disease severity in children with respiratory syncytial virus infection, American Journal of Respiratory and Critical Care Medicine, vol.194, issue.9, pp.1104-1115, 2016.

S. M. Teo, D. Mok, and K. Pham, The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development, Journal of Immunology Research, vol.17, issue.5, pp.704-715, 2015.